Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Recruiting

Phase 2

Myeloablative ConditioningMyeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Sponsor:

New York Medical College

Code:

NCT02675959

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 6 - 34

Healthy Volunteers: Not accepted

Interventions

Defibrotide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-15. This information was provided to ClinicalTrials.gov by New York Medical College on 2025-05-23.